In addition, OVA-specific antibody production and CD8+ T-cell activation analyzed by tetramer assays were detected only in MnJ-OVA-immunized WT mice (Fig. 6m, n and Supplementary Fig. 8q), suggesting systematic activation of the antitumor adaptive immune response as well as its potential in tumor therapies. Here, CD8A is linked to neoplasm.